Soluble immune markers in the different phases of chronic hepatitis B virus infection

Soluble immune markers in the different phases of chronic hepatitis B virus infection

Abstract Chronic hepatitis B virus (HBV) infection may follow four different consecutive phases, which are defined by virology as well as biochemical markers and differ in terms of prognosis and need for antiviral treatment. Currently, host responses reflected by immune markers are not considered in...

Full description

Bibliographic Details
Main Authors: Steffen B. Wiegand, Bastian Beggel, Anika Wranke, Elmira Aliabadi, Jerzy Jaroszewicz, Cheng-Jian Xu, Yang Li, Michael P. Manns, Thomas Lengauer, Heiner Wedemeyer, Anke R. M. Kraft, Christine S. Falk, Markus Cornberg
Format: Article
Language:English
Published: Nature Portfolio 2019-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-019-50729-5

Internet

https://doi.org/10.1038/s41598-019-50729-5

Similar Items